select study semaglutide Recent finds that medication may benefit 93 million U.S. adults New Science Suggests Semaglutide Improves

Except as outlined above, we will not use or disclose your PHI for any other purpose unless you have signed a form authorizing the use or disclosure

Retatrutide Side Effects As with many GLP-1 agonists, "Retatrutide side effects" primarily involve gastrointestinal discomforts, including nausea or diarrhea, reported during trials

This research clearly indicates that GLP-1 is once again the star of the show

The same trial also notes that the SEMALEAN study (2025): "Patients experienced an average weight loss of 12 kg after 6 months of treatment with Semaglutide", showing significant total-body change along with the internal change

What ethical considerations might arise when prescribing medication that is also widely used for weight loss in nondiabetic patients